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The Ia (I region associated) antigenic system in the mouse is coded for by genes located 
within the H-2 complex and consists  of at least four subregions (IA, IB, IE,  AND IC) 
which code for a minimum of  21 (Ia. 1 to 21) specificities (1-3), although the existence of  IB 
and IE subregions is now being questioned. These antigens were first detected on the 
surface of B lymphocytes and were subsequently found on macrophages, epidermal cells, 
and sperm cells (4). It is also apparent that some Ia specificities are present on either 
resting and  activated T-blast cells  (2-8). In addition,  we  have detected considerable 
amounts of Ia antigenic material in mouse serum and other tissue fluids,  particularly 
after antigenic stimulation (8, 9). The current interest in this system stems from the close 
involvement of the I  region in  immune  responses  (1-3),  especially with the  recent 
demonstration that soluble factors of both antigen-specific  and nonspecific nature which 
are involved in T-B cell collaboration (10, 11) and suppression  (12), also carry Ia antigens. 
In this context, we have found that although B cells have a higher density of Ia antigens 
on their surface than T cells, the Ia antigens in serum are derived from T cells (9). 
Biochemical studies of the Ia specificities have proceeded along two lines. The 
cell surface Ia antigens of B cells have been extracted with detergents and were 
found to be  glycoproteins with  mol  wt  of approximately 30,000  (13,  14). By 
contrast,  our  chemical  studies  of the  serum  Ia  material  suggest  that  it  is 
predominantly (but not exclusively) carbohydrate in nature as the material has 
the  following properties:  (a)  It is  rich in  carbohydrate and  almost devoid of 
protein (15); (b) The Ia antigenicity is destroyed by neuraminidase and perio- 
date, but not by pronase (15); (c) The Ia antigen binds to concanavalin A  and 
Lotus  lectins  (15);  (d)  It  is  extracted  and  purified from serum  by  methods 
identical to those used to prepare oligosaccharides from human milk (15-17); (e) 
Its behaviour on paper and thin layer chromatography is similar to that of other 
oligosaccharides  (15),  and  after  acid  hydrolysis of the  purified Ia  product a 
number  of simple  sugars  have  been  detected by gas-liquid  chromatography 
(manuscript in preparation). In this paper, we describe hapten inhibition stud- 
ies using a  variety of sugars that show that for at least four Ia antigens (Ia.1, 
Ia.3, Ia.7, and Ia.15) the antigenic specificity is defined by sugars. 
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Materials and Methods 
Mice.  The mice used are shown in the tables. The various strains are maintained inbred at the 
Austin Hospital and were originally obtained from several sources (8). 
Antisera.  Inhibition studies were performed with both conventional mouse anti-Ia sera and 
also with our new rabbit anti-Ia sera. The alloantisera were prepared as described elsewhere (8, 9). 
The  specificities detected  by  the  A.TH  anti-A.TL  (AS  383)  serum  are  shown in  Table  I.  By 
selecting a variety of target cells, different specificities could be detected. The heterologous rabbit 
anti-P was prepared as reported previously  (8).  Briefly,  rabbits were immunized with CBA/H 
whole mouse serum and the resultant rabbit antiserum extensively absorbed with dialyzed CBA/ 
H serum. The rationale for this preparative method is that the bulk of the serum Ia material is of 
low molecular weight and is therefore dialyzable, and is thus removed from the CBA/H serum 
used for the absorption. As we shall subsequently report (manuscript in preparation) the rabbit 
anti-I  k serum contains all of the specificities found in the alloantiserum (shown by absorption and 
by reaction with different target cells). The anti-H-2 sera used were D4, Da, D28, and D31. These 
sera are described in the Catalogue of Mouse Alloantisera and were obtained from the Transplan- 
tation  Division,  National  Institute  of Allergy  and Infectious  Diseases,  National  Institutes of 
Health, Bethesda, Md. The anti-H-2 antisera were used at concentrations giving 90% lysis of the 
target cells: D4  (1/125);  D8 (1/64); D13 (1/250); D28 (1/64);  D28b (1/32); and D31  (1/500), and any 
inhibition from this value was sought. It should be noted that these H-2 antisera could potentially 
contain anti-Ia antibodies relevant to the H-2  d (BALB/c) target. These should be Ia.6 (in D4, D13, 
D28b) which is present in very low titers and not of relevance to these studies. D31 contains anti- 
Ia.ll,  16. The titer of anti-Ia.16 is 1/64,  and we believe (from other studies) that the Ia.ll titer is 
similar.  These  anti-Ia  antibodies  are  therefore  probably not  of relevance  in these  particular 
inhibition studies. 
Sugars.  The sugars used are listed in the tables and were obtained as follows: v-galactose and 
L-arabinose were from Merck Ag, Darmstadt, Germany. D-glucuronic acid, D-galacturonic acid, D- 
mannose, and L-fucose were from BDH Chemicals Ltd., Poole, England. D-fucose, D-glucosamine,l 
D-galactosamine, D-xylose,  v-lyxose, cellobiose, and maltose were from Calbiochem, San Diego, 
Calif. N-acetyl-D-glucosamine, N-acetyl-D-galactosamine, N-acetyl-D-mannosamine, v-glucose, D- 
talose, melibiose, raffinose, stachyose, lactose, lactulose, L-rhamnose, n-ribose, sucrose, sorbose, 
methyl-a-D-glucopyranoside,  methyl-a-D-mannopyranoside,  and N-acetylneuraminic  acid  were 
from Sigma Chemical Co.,  St.  Louis,  Mo.  D-galactonolactone was from Kochlight Laboratories, 
Colnbrook, Buckshire, England. Phenyl-a-D-galactopyranoside and phenyl-B-D-galactopyranoside 
were obtained as a  gift from Dr M. A. Germyn, CSIRO,  Victoria, Australia.  These sugars were 
dissolved in phosphate-buffered saline (PBS)  2 at a concentration of 20 mg/ml. In some cases the pH 
was readjusted to 7.2 with 0.1 M NaOH. 
Hapten-Inhibition  Assays.  Two  assays were  used  similar to  those described  in our earlier 
studies (8,  9). 
INHIBITION OF CYTOTOXICITY  OF ANTI-Ia ALLOANTIBODY.  The anti-Ia serum was titered against 
the  appropriate  spleen  cell  target  (Table  I)  and  a  suitable  dilution  selected  for  subsequent 
inhibition studies (8), i.e.,  one tube less than the highest dilution causing maximum cell lysis. 
Doubling dilutions of each sugar solution were made in L15  (Microbiological Associates,  Balti- 
more,  Md.) containing 0.5% bovine serum albumin (Miles Laboratories, Inc.,  Elkhart, Ind.), so 
that the first well contained  1 mg of the  sugar in 50  tzl  of the  L15  medium.  50  ~1 of anti-Ia 
antiserum at the appropriate dilution was then added to each well, and the test then left at room 
temperature  for  2  h,  the  final  concentration  of the  sugar  in  the  first  well  being  10  mg/ml. 
Subsequently, spleen cells and complement were added and a cytotoxic test performed as described 
previously (8). 
INHIBITION OF ROSETTING BY RABBIT ANTI-Ia.  The binding of rabbit anti-Ia antibodies to spleen 
cells was detected by a  rosetting technique using sheep red blood cells (SRBC) coated with sheep 
anti-rabbit IgG via chromic chloride (8). A dilution of the rabbit antiserum was chosen which was 
1The  common  names  D-glucosamine,  N-acetyl-D-glucosamine,  D-galactosamine,  N-acetyl-D- 
galactosamine,  and N-acetyl-D-mannosamine refer to 2-amino-2-deoxy-D-glucose, 2-acetamido-2- 
deoxy-D-glucose, 2-amino-2-deoxy-D-galactose, 2-acetamido-2-deoxy-D-galactose, and 2-acetamido- 
2-deoxy-D-mannose, respectively. 
2  Abbreviations used in this paper: PBS, phosphate-buffered saline; RFC, rosette-forming cells. I.  F.  C.  McKENZIE,  A.  CLARKE,  AND  C.  R.  PARISH 
TABLE  I 
Antisera and Target Cells Used in the Hapten Inhibition Studies 
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Titer for inhibi- 
Antiserum  Target cell (Ia specificities)  tions  Ia specificities  detected 
A.TH  anti-A.TL  BI0.M  (H-2  t)  1/512  la.l 
(anti-la.l, 2, 3, 7, 15, 19)  (la.l, 5, 14, 17, 18) 
C57BL/6 (H-2  ~)  1/1,000  la.3 (15)* 
(la.3, 5, 9, 15, W20) 
BALB/c  (H-2  ~)  1/1,000  la.7 (15)* 
(la.6, 7, 8, 11, 15, 16) 
D2.GD (H-2 ¢2)  1/256  Ia. 15 
(Ia.8, 11, 15, 16) 
C3H (H-2 ~ }  1/2,000  Ia.1, 2, 3, 7, 15, 19 
(la.1, 2, 3, 7, 15, 17, 18, 19) 
Rabbit anti-I  A  A.TFR2 (H-2 °~ )  1/25  Ia.1 (17, 18)$ 
(anti-la.1, 2, 3, 7, 15, 17, 18, 19)  (la.1, 5, 14, 17, 18) 
DBA/1 (H-2 q )  1/50  Ia.3 
(Ia.3,  5, 9,  10, 13, 16) 
BALB/c (H-2 d)  1/100  Ia.7 (15)* 
(Ia.6,  7, 8,  11, 15, 16) 
D2.GD (H-2 ~  )  1/25  Ia.15 
(Ia.8,  11, 15, 16) 
* Antiserum used at a dilution where specificity  15 is barely detected. 
* Antiserum absorbed with A.TH spleen cells to remove anti-17, 18 antibodies. 
one tube less than the highest dilution that produced maximum rosetting. 50 ~l of this antibody 
dilution was added to serial dilutions (50/~l) of the various sugars, and the mixture was incubated 
at room temperature for 2 h. In these tests the first well contained 200 ~g of sugar. 100 ~1 of spleen 
cells (2 ×  107/ml in PBS/10% fetal calf serum) of the appropriate haplotype (see Table I) were then 
added to each tube and the rosetting test performed as previously described (8). 
In both inhibition assays, inhibitory activity was expressed as the sugar concentration which 
caused a  50% reduction in cell lysis or a  20% reduction in the formation of rosette forming cells 
(RFC).  The concentrations stated in the tables and figures represent the sugar concentration in 
the assays after the addition of anti-Ia serum. 
Results 
Inhibition of Different Anti-Ia Sera with Sugars.  The ability of a range of 
monosaccharides and glycosides to inhibit the binding of allogeneic and xenoge- 
neic anti-Ia antibodies to mouse lymphocytes was assessed. Target lymphocytes 
of the appropriate I-region haplotype were chosen so that Ia specificities 1, 3, 7, 
and 15 could be examined (Table I).  The results are presented in Tables II-IV 
and in Figs. 1 and 2. The values shown in the tables represent the concentration 
of sugar which, in the case of the allogeneic anti-Ia sera, caused a 50% reduction 
in cell lysis or which produced, in the case of the xenogeneic anti-Ia sera, a 20% 
reduction in RFC. The results obtained with the different Ia specificities are 
considered separately below. 
Inhibition of Anti-Ia.1 Antibodies.  Inhibition of  the Ia.1 reaction was exam- 
ined using the A.TH anti-A.TL alloantiserum and B10.M target cells; or in the 
xenogeneic  system  using A.TFR2  target  cells  and  the  rabbit  anti-1  ~  serum 
absorbed  with  A.TH  spleen  cells  (Table  I).  In both assay systems the  most 50 
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effective inhibition was obtained with N-acetyl-v-mannosamine (Table II).  I~ 
mannose and methyl-a-D-mannopyranoside  were also effective inhibitors but at 
higher concentrations than N-acetyl-D-mannosamine. No  inhibition was  pro- 
duced by any of the other sugars used even at concentrations as high as 55 mM 
(Table  II).  It  should  be  noted  that  both  assay  systems  were  performed  in 
different laboratories and gave the same results. The results suggest that N- 
acetyl-D-mannosamine is the immunodominant sugar for the Ia. 1 specificity. 
Inhibition of  Anti-Ia.3 Antibodies.  The Ia.3 reaction was measured by react- 
ing the  allogeneic A.TH anti-A.TL serum with C57BL/6 target cells.  In this 
system Ia.3 and Ia. 15 antigenic specificities could potentially be detected (Table 
I).  However, the serum was used at a  dilution of 1/2,000,  which is well beyond 
the range of reaction for Ia.15 (1/200 on D2.GD target cells). In the RFC system, 
DBA/1 was used as the target cell as in this combination only Ia.3 is recognized 
by the rabbit antiserum. The most effective monosaccharide inhibitor was D- 
galactose (inhibition with 2.10  and 0.69  mM solutions in the cytotoxicity and 
RFC inhibition assays, respectively) (Table II). Other hexose sugars such as D- 
glucose, D-mannose, and L-fucose did not inhibit the reaction (at concentrations 
up to 55 mM), nor did any of a number ofpentose sugars tested. However, sugars 
related to galactose in which only substitution at C-2 was involved, such as N- 
acetyl-D-galactosamine, D-galactosamine, or D-talose, which differs from galac- 
tose only in the orientation of the hydroxyl group at C-2,  were also effective 
inhibitors. Some oligosaccharides with a terminal nonreducing D-galactose unit, 
namely melibiose, raffinose, and stachyose, were also effective inhibitors. Inhi- 
bition was also obtained with D-galacturonic acid and with the glycoside phenyl- 
a-D-galactopyranoside, but not with phenyl-/3-D-galactopyranoside, nor with the 
galactose-containing disaccharides, lactose or lactulose. The immunodominant 
sugar for the Ia. 3 antigenic specificity thus appears to be a-linked D-galactose. 
Fig.  1 compares  in  more detail the  ability of several  galactose-containing 
sugars to inhibit the binding of either allogeneic (Fig. 1 a) or xenogeneic (Fig. 
1 b) anti-Ia antibodies to mouse spleen cells. Although slightly higher concentra- 
tions of the various sugars were required to inhibit the binding of the alloanti- 
bodies than the xenoantibodies, the hierarchy of  inhibition was the same in both 
assays, i.e., raffinose >  D-galactose >  D-galactosamine > N-acetyl-D-galactosa- 
mine. 
Inhibition of Anti-Ia.7 Antibodies.  The Ia.7 specificity was detected by the 
reaction of the A.TH anti-A.TL mouse serum or the rabbit anti-1  ~ serum with 
BALB/c (H-2  a) cells. In both cases Ia. 15 could be potentially detected, but the 
antisera were used at dilutions above which Ia. 15 is detected (Table I). The only 
sugar that produced complete inhibition was L-fucose which inhibited at compa- 
FIG. I.  Comparison of the ability of several galactose containing sugars to inhibit the 
binding of  anti-la. 3 antibodies to mouse spleen cells.  The sugar inhibitors are  N-acetyl-D- 
galactosamine (A), D-galactosamine (O), D-galactose (D),  and raffinose  (.).  The dotted  line 
represents the percent lysis or percent RFC  in the absence of any inhibitor or in the 
presence  of  a noninhibitory sugar. The antisera and target cells  used are  presented  in  Table 
I. (a) Inhibition of  cytotoxicity  of allogeneic anti-Ia. 3 serum. The percent lysis  of spleen 
cells incubated with complement  alone is indicated  (O). (b) Inhibition of rosetting of 
xenogeneic anti-Ia.  3 serum. 1044  OLIGOSACCHARIDE  NATURE  OF  Ia  ANTIGENS 
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FIG.  2.  Comparison of  the ability of L-fucose  ([3) or v-galactose (.) to inhibit the cytotoxic- 
ity of an allogeneic anti-Ia.  7 serum on BALB/c spleen cells. The nature of the antiserum 
and target cell used  is described in detail in Table I.  The percent lysis  of spleen  cells 
incubated with complement alone is indicated (0). 
rable concentrations in both inhibition assay systems (Table III, Fig.  2). Apart 
from sialic acid (N-acetylneuraminic acid) which inhibited at a concentration of 
16.17 mM in the cytotoxicity but not in the rosetting system, no other sugar gave 
any inhibition. In particular, there was no inhibition by D-fucose. Thus, L-fucose 
is implicated in the Ia.7 specificity. 
Inhibition  of Anti-Ia.15  Antibodies.  The  Ia.15  specificity  in  both  assay 
systems was detected by using D2.GD target cells (Table I). In both inhibitory 
assays, N-acetyl-D-glucosamine caused significant inhibition:  1.36 mM by cyto- 
toxicity and 0.14 mM by RFC inhibition (Table III). However, no inhibition was 
detected by other sugars  related to glucose.  Apart from N-acetyl-D-galactosa- 
mine, which gave some inhibition in both assays, there was no inhibition by any 
of the other monosaccharides, disaccharides, or oligosaccharides tested.  On the 
basis  of this data,  it was  concluded that the Ia.15  specificity is defined by N- 
acetyl-D-glucosamine. 
Inhibition of Anti-I  A" Serum  (Ia.1, 2, 3, 7, 15, 19).  When the alloantiserum 
A.TH anti-A.TL was reacted with H-2  k target cells at a concentration of 1/1,000 
a composite picture was obtained as several Ia specificities were detected simul- 
taneously.  However, the antiserum  was used at a  concentration that detected 
mainly the  Ia.1,  Ia.3,  and  Ia.7  specificities.  The  Ia.15  reaction would  not  be 
detected, and the alloantiserum  contains  anti-Ia.2  antibody to a  titer of 1/128 
and would probably not have been detected; also we have no information as to 
whether the antiserum contains any anti-Ia. 19 antibodies.  We found inhibition 
with D-mannose, D-galactose, and L-fucose (Table IV) which is in accord with the 
detection  of Ia  specificities  1,  3,  and  7,  respectively,  as  described  above.  In 
addition,  there was some inhibition by N-acetylneuraminic acid,  but,  as with 
other specificities, this was considerably less than the inhibition obtained with 
other sugars. I.  F.  C.  McKENZIE,  A.  CLARKE,  AND  C.  R.  PARISH  1045 
TABLE  II 
A bility of  Different Sugars to Inhibit the Binding of  AUogeneic and Xenogeneic A nti-Ia.1 
and Anti-Ia.3 Antibodies to Mouse Spleen Cells* 
Sugar inhibitor 
Sugar concentration (mM) required for inhibitions 
Ia.1  Ia.3 
Allogeneic  Xenogeneic  Allogeneic  Xenogeneic 
anti-Ia  anti-Ia  anti-Ia  anti-Ia 
Monosaccharides 
D-galactose  -- §  -- §  2.10  0.69 
N-acetyl-D-galactosamine  -  -  29.0  9.04 
v-galactosamine  --  --  5.80  2.32 
D-galacturonic acid  -  -  6.44  NT 
D-glucose  .... 
N-acetyl-D-glucosamine  .... 
D-glucosamine  .... 
D-glucuronic acid  .... 
v-mannose  13.87  5.55  --  -- 
N-acetyl-v-mannosamine  2.72  0.54  -  - 
N-acetylneuraminic acid  .... 
D-talose  -  NT  6.94  NT 
D-fucose  .... 
L-fucose  .... 
D-ribose  .... 
L-rhamnose  .... 
L-arabinose  .... 
D-lyxose  .... 
D-xylose  .... 
Glycosides 
Phenyl- a-v-galactopyranoside  -  NT  4.87  NT 
Phenyl-/3-D-galactopyranoside  -  NT  -  NT 
Methyl- a-v-glucopyranoside  --  NT  -  NT 
Methyl- a-D-mannopyranoside  12.87  5.15  --  -- 
Oligosaccharides 
Melibiose  -  NT  0.87  NT 
Raffinose  -  -  0.52  0.12 
Stachyose  -  NT  0.90  NT 
Lactose  .... 
Lactulose  -  NT  -  NT 
Maltose  .... 
Cellobiose  .... 
Sucrose  NT  -  NT  - 
NT, not tested. 
* Nature of the antisera and target cells presented in Table I. 
S Values  represent the  concentration  of sugar needed  to  inhibit  either  the  cytotoxicity  of the 
allogeneic anti-Ia by 50%  or the rosetting of the xenogeneic anti-Ia by 20%. 
§  -,  no inhibition by sugar at 10 rng/ml (>55.5 mM for glucose) in the allogeneic anti-Ia assay and 
2 mg/ml (>11.1  mM for glucose) in the xenogeneic anti-Ia assay. 
Sugar Inhibition  Studies  With H-2  Antisera.  The  experiments  described 
above  suggest  that  many  of the  I-region-associated  antigenic  specificities  are 
defined  by sugars.  We  then  carried  out  experiments  to determine  whether  H-2K 
and  H-2D  region-defined  antigens  are  also  sugar  in  nature  by  measuring  the 1046  OLIGOSACCHARIDE  NATURE  OF  Ia  ANTIGENS 
TABLE  III 
Ability of  Different Sugars to Inhibit the Binding of  Allogeneic and Xenogeneic A nti-Ia. 7 
and Anti-Ia.15 Antibodies to Mouse Spleen Cells* 
Sugar concentration  (mM) required for inhibition 
Sugar inhibitor 
Ia.7  Ia.15 
Allogeneic  Xenogeneic  Allogeneic  Xenogeneic 
anti-Ia  anti-Ia  anti-Ia  anti-Ia 
Monosaccharides 
D-ga!actose  .... 
N-acetyl-D-galactosamine  --  --  5.65  2.26 
D-galactosamine  .... 
D-galacturonic acid  .... 
D-glucose  .... 
N-acetyl-D-glucosamine  --  --  1.36  0.14 
D-glucosamine  .... 
D-glucuronic acid  .... 
D-mannose  .... 
N-acetyl-D-mannosamine  .... 
N-acetylneuraminic acid  16.17  -  32.34  - 
D-talose  --  NT  -  NT 
D-fucose  .... 
L-fucose  1.87  0.75  --  -- 
D-ribose  .... 
L-rhamnose  .... 
L-arabinose  .... 
D-lyxose  .... 
D-xylose  .... 
Glycosides 
Phenyl-  a-D-galactopyranoside  --  NT  -  NT 
Phenyl-/3-D-galactopyranoside  --  NT  -  NT 
Methyl- a-D-glucopyranoside  -  NT  -  NT 
Methyl- a-D-mannopyranoside  .... 
Oligosaccharides 
Melibiose  -  NT  -  NT 
Raffinose  .... 
Stachyose  -  NT  -  NT 
Lactose  .... 
Lactulose  -  NT  -  NT 
Maltose  .... 
Cellobiose  .... 
Sucrose  NT  -  NT  - 
* Footnotes as in Table II. 
ability  of  a  range  of sugars  to  inhibit  the  cytotoxicity  of anti-H-2  antisera  for 
BALB/c  spleen  cells,  the  antisera  used  were  able  to  detect  the  private  H-2 
specificities  of H-2 't (i.e.,  H-2D.4  and  H-2K.31),  and  the  public  H-2 d specificities 
(i.e.,  H-2.8,  13,  27,  28 and  29).  The  sera  used  were  D4,  D8,  D13,  D28,  D28b,  and 
D31,  which  were  all obtained  from  the  Catalogue  of Mouse  and  Alloantisera.  We 
were  unable  to find  inhibition  by any  of the  sugars  used  in the  Ia antigen  studies 
(Tables  II  and  III)  at  concentrations  up  to  55  mM. I.  F.  C.  McKENZIE~  A.  CLARKE,  AND  C.  R.  PARISH 
TABLE  IV 
Ability of  Different  Sugars to  Inhibit the Binding of  AUogeneie 
Anti-I  k  Antibodies to C3H Spleen Cells* 
Sugar concentration 
Sugar inhibitor  (mM) required for inhi- 
bitions 
D-galactose  13.9 
N-acetyl-~galactosamine  11.3 
D-glucose  >55.5 
N-acetyl-D-glucosamine  >45.2 
D-mannose  5.5 
N-acetyl-D-mannosamine  4.5 
N-acetylneuraminic acid  16.2 
L-fucose  6.1 
Cellobiose  >29.2 
Maltose  >29.2 
* A.TH anti-A.TL serum as in Table I  used at i/I,000  dilution. 
Values represent the concentration of sugar needed to inhibit the 
cytotoxicity  of  the antiserum by 50%. 
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Discussion 
Using both allogenic and xenogenic antisera,  our results show that sugar 
residues are involved in the Ia antigen specificities 1, 3, 7, and 15. The individ- 
ual specificities involve N-acetyl-D-mannosamine, D-galactose, L-fucose, and N- 
acetyl-D-glucosamine, respectively (Table  V).  In contrast,  several public  and 
private H-2 antigenic specificities did not appear to be sugar defined, a finding 
consistent with other studies (18). The results, to be described separately, are 
interpreted in terms of Landsteiner's (19) observation that a  substance with a 
structure related to the determinant group of an antigen can combine with the 
antibody and thus competitively inhibit the antibody-antigen reaction. As the 
structural  relationship  between  the  simple  substance  and  the  determinant 
group becomes closer, the concentration required to inhibit the antigen-antibody 
reaction becomes lower. 
Inhibition of Anti-Ia.1 by D-Mannose and Related Sugars.  The finding that 
mannose substituted at position two with an acetamide group is a more effective 
inhibitor than either mannose or methyl-a-D-mannopyranoside suggests that a 
two substituted mannose unit is involved in the determinant group. As the most 
effective inhibitor, N-acetyl-D-mannosamine is not a commonly found constitu- 
ent of mammalian glycoproteins; it seems more likely that mannose substituted 
with another sugar at position two is involved, but resolution of this point must 
await further tests with mannose-containing oligosaccharides. 
Inhibition of Anti-Ia.3 by D-Galactose and Related Sugars.  Inasmuch as a 
range of  sugars inhibited the Ia.3 reaction a more detailed analysis of  the nature 
of this  specificity was  possible.  For  this  specificity galactose  was  the  most 
effective inhibitor of all the monosaccharides tested,  and all the sugars that 
inhibited the reaction were related to galactose (see Table II). 
On the basis of  the monosaccharide inhibitors it appears that the nature of  the 
substituent at C5 in the hexose sugar influences the efficiency of  the sugar as an 
inhibitor, i.e., galactose, which has a primary alcohol at C5, is the most efficient 1048  OLIGOSACCHARIDE  NATURE  OF  Ia  ANTIGENS 
TABLE V 
Immunodominant  Sugar in Different Ia Antigenic Specificities 
as Judged  by Hapten-Inhibition Studies 
Specificity  Immunodominant sugar 
Ia. 1  N-acetyl-v-mannosamine 
Ia. 3  a-v-galactose 
Ia.7  L-fucose 
Ia. 15  N-acetyl-D-glucosamine 
inhibitor, while oxidation of this substituent as in galacturonic acid decreases 
its efficiency (Fig. 3). If the substituent is reduced as in v-fucose or absent as in 
L-arabinose,  the  ability of the  sugar to  inhibit the  reaction is  lost  (Fig.  3). 
Furthermore, the  orientation of the  hydroxyl groups  at  C4  must be  that of 
galactose for the sugar to be an effective inhibitor as neither glucose, mannose, 
nor their derivatives inhibited the reaction. Glucose differs from galactose only 
in the orientation of the C4 hydroxyl, while mannose differs from galactose in 
the orientation of both C2 and C4 hydroxyls (Fig. 4). However, sugars differing 
from galactose  only in  their  C2  substituents  (e.g.,  v-galactosamine and N- 
acetyl-D-galactosamine) are effective as inhibitors, e.g.,  D-talose  which differs 
from galactose only in the orientation of the C2 hydroxyl (Fig. 4). 
These results suggest that D-galactose or a closely related sugar is involved in 
the determinant group of Ia.3, the C4 configuration of galactose being essential 
for antigenicity, whereas the C2 and C5 configurations play less important roles. 
The predominance of C4 in antigenicity is consistent with the galactose being at 
the terminal nonreducing end of a  sugar sidechain. 
Tests with the phenyl-galactosides showed that only the a-linked galactoside 
was an inhibitor, and this suggested that the determinant would probably be in 
a-linkage. The a-linkage requirement was confirmed with tests on a  series of 
oligosaccharides. These tests showed that oligosaccharides having a  terminal 
nonreducing galactose  unit  in  a-linkage,  such  as  melibiose,  raffinose,  and 
stachyose, were effective inhibitors, while disaccharides having terminal nonre- 
ducing galactose units in B-linkage,  such  as  lactose and lactulose, were not 
inhibitors (Table VI). The ineffectiveness of mannose and glucose as inhibitors 
was confirmed by the observation that neither methyl-a-glucoside nor methyl- 
a-mannoside were inhibitors:  Similarly, the disaccharides maltose and cello- 
biose, which possess terminal nonreducing glucose units linked a and fl, respec- 
tively, were not effective as inhibitors. Collectively, these results indicate that 
v-galactose or a  closely related sugar is involved in the determinant group of 
Ia.3, and that the sugar is probably in a-linkage. 
Inhibition  of Anti-Ia.7  by  L-Fucose.  Apart  from N-acetylneuraminic acid 
which inhibited at high concentrations, L-fucose was the only sugar tested which 
inhibited in either assay system. Both these sugars are known to be present as 
terminal  groups  in  mammalian  glycoproteins.  The  enantiomorph  D-fucose, 
which does not occur naturally in mammalian sources and was included in the 
test primarily because of its structural relationship to D-galactose, was not an 
inhibitor. 
Inhibition  of Anti-Ia.15  by  N-Acetyl-D-Glucosamine.  Anti-Ia.15  was  in- 
hibited by low  concentrations of N-acetyl-D-glucosamine but  not by glucose, I.  F.  C. 
× 
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X .= -CH 2OH  D-Galactose 
X = -H  L-Arabinose 
X = -CH  3  D-Fucose 
X = -COOH  D-Galacturonic acid 
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FIG. 3.  The structure  of some of the monosaccharides used in the hapten-inhibition 
studies and particularly relevant  to  an understanding of  the structure of  the Ia. 3 antigenic 
specificity  (see  Discussion). 
CH2OH  CHzOH  CH2OH  o 
D-Galactose  D-Glucose  D-Mannose  D-Talose 
FIG.  4.  Structure of some additional monosaccharides used in the hapten-inhibition stud- 
ies. 
glucuronic acid,  D-glucosamine, methyl-a-D-glucopyranoside,  or either the ~- or 
fl- (1 --, 4) linked  glucose  disaccharides,  maltose  or cellobiose (Table  VI). 
However, N-acetyl-D-galactosamine  was a moderate inhibitor, whereas N-ace- 
tyl-D-mannosamine  showed no inhibition, a result that suggests that the ori- 
entation of  the C2 acetyl group is important in determining antigenicity. Thus, 
these studies implicate N-acetyl-D-glucosamine  (2-acetamido-2-deoxy-D-glucose) 
or a related sugar in the determinant group. This is  in keeping with the general 
finding that this  sugar is present in mammalian  cell  membrane  glycoproteins 
but that glucose itself  is rarely present. 
The four sugars that we have found to  be involved in the la antigens of  mice, 
namely D-mannose, D-galactose, L-fucose,  and N-acetyl-D-glucosamine,  are fre- 
quently found in the glycoproteins of mammalian  cell  membranes.  L-fucose is 
always found as a terminal nonreducing group, and D-mannose, D-galactose,  and 
N-acetyl-D-glucosamine  can occur as either  end groups or core groups in glyco- 
proteins (20). In fact, on the basis of our findings there now appears to be a 
remarkable similarity  between the la  antigens and the human ABO  blood group 
substance specificities,  as both antigen systems can occur as cell membrane 
determinants as well as serum glycoproteins, and in both systems the antigenic 
determinants are defined by terminal sugar sequences. Furthermore, the exper- 
imental approach described  in this paper is similar to the classical work of 
Morgan and Watkins  (21)  who showed that L-fucose specifically  inhibited the 
hemagglutination  of human  O  cells  by extracts of  Lotus tetragonolobus  and of 
Kabat and Ginsberg et al. (22,  23) who (a) showed that N-acetyl-D-galactosa- 
mine inhibited the lectin-induced hemagglutination  of  blood group A cells  and 
who (b) demonstrated that the reaction of  blood group B with anti-B antibody 
could be inhibited by various a-linked D-galactosides. However,  although we 
have shown that different  monosaccharides are implicated in each la specificity 
studied, this  does not necessarily imply that the total  specificity  resides in the 
terminal sugar. It would be anticipated that the Ia antigenic specificities  are 
spread over several sugar units as has been shown for most antigenic determi- 1050  OLIGOSACCHARIDE  NATURE  OF  Ia  ANTIGENS 
TABLE  VI 
Structures of the Different  Oligosaccharides  Used in the Inhibition 
Studies 
Oligosaccharide  Structure 
Melibiose 
Lactose 
Lactulose 
Maltose 
Cellobiose 
Sucrose 
Raffinose 
Stachyose 
O- a-D-Gal-  (  1--~6)-D-Glc 
O-~-v-Gal-(1--*4)-a-D-Glc 
O-B-D-Gal- (1---4)-  a-D-Fru 
O-a-n-Glc-(1--*4)-  a-u-Glc 
O-B-D-GIc-(1--*4)-a-D-Glc 
O- a-v-Glc-(1--*2)-~-mFru 
O-a-D-Gal-  (1--6)-  a-D-Glc-(1-*2)-B-D-Fru 
O-a-v-Gal-(1---~6)-a-D-Gal-(1--*6)-a-D-Glc-(1-*  2)-/3-D-Fru 
nants  (24).  Consistent with this interpretation  are preliminary  studies in our 
laboratories which have also implicated galactose in the Ia.8 and Ia.9 specifici- 
ties. 
Our  studies  therefore  demonstrate  that  the  specificity of at  least  four  Ia 
antigens present on the surface of splenic B cells resides in the carbohydrate, 
rather than protein moiety of these cell surface glycoproteins. Presumably, the 
same conclusion holds for the Ia antigen-bearing  oligosaccharide(s)  which we 
have recently isolated from mouse serum (8, 9, 15) and which constitute >98% of 
the Ia antigenic activity detected in normal serum. In this context it should be 
noted that human ABO blood group substances can also exist in several molecu- 
lar forms,  such  as low molecular weight oligosaccharides,  glycoproteins,  and 
glycolipids. In agreement with the ABO system, we have recently identified a 
high molecular weight serum glycoprotein in mouse serum, which also bears Ia 
antigenic determinants  (25). Whether the Ia specificities reside in the carbohy- 
drate or peptide fraction of the cell surface glycoproteins has been previously 
questioned,  and  there  is  some  evidence,  contrary  to  our  data,  of specificity 
residing in the protein moiety (26).  However, these studies have not resolved 
whether the amino acid moiety participates directly in the serological specificity 
or  whether  it  merely  maintains  the  carbohydrate  side chains  in  the  correct 
conformation.  Our studies clearly implicate carbohydrate as playing an immu- 
nodominant  role in the Ia specificities.  It is of interest that the relative roles 
played by carbohydrate or protein in defining the HLA specificities in man does 
not as yet appear to have been settled (27). 
Our demonstration that several of the Ia antigens are defined by sugars has 
several important  theoretical  implications.  First,  it strongly suggests that  at 
least some of the  genes in the I  region  of the H-2  complex code for glycosyl 
transferases. Furthermore, based on the Ia specificities examined, both the I-A 
(Ia.1,  3,  15)  and I-C  (Ia.7)  subregions  (2)  should contain  glycosyl transferase 
genes.  Second,  the  close relationship  between Ia  antigens  and  many  T-cell- 
derived immunoregulatory substances (10-12) suggests that carbohydrates may 
play  a  role  in  T-B  cell  collaboration.  Finally,  the  fact that  Ia  antigens  are 
oligosaccharide in nature  must be borne in mind when attempts are made to 
develop  a  relationship  between Ia  antigens  and  Ir  genes  and  their  role  as 
recognition units. In this light, it should be recalled that carbohydrate determi- 
nants have been shown to be involved in a variety of recognition processes, such I.  F.  C.  McKENZIE,  A.  CLARKE,  AND  C.  R.  PARISH  1051 
as sponge cell reaggregation (28), plant pathogen-host recognition (29), embry- 
onic  development  (30),  hemagglutination  by plant  lectins  (30,  31),  platelet- 
collagen adhesion (30, 32), and the removal from the circulation ofglycoproteins 
lacking their terminal sialic acid groups (30, 33). The carbohydrate nature of the 
Ia  specificities and their possible  role  in T-B  cell collaboration  may provide 
another example of the important role of carbohydrates as informational mole- 
cules.  Superficially, it might appear that Ia antigens possess certain genetic 
characteristics which are difficult to reconcile with the Ia gene product being a 
glycosyl transferase. First, is it possible for one I  subregion to code for multiple 
Ia antigenic specificities (1-3) ifglycosyl transferases are involved? The simplest 
explanation is that each I  subregion consists of a  cluster of genes coding for 
glycosyl transferases which act very specifically in sequence to construct an 
oligosaccharide sidechain. Certainly our observation that two of the I-A  subre- 
gion specificities  (i.e.,  specificities one and three) in the H-2 k  haplotype are 
defined  by  different  sugars  is  consistent  with  this  subregion  containing  a 
number of glycosyl transferase genes. Second, if the Ia gene product is a glycosyl 
transferase would it be possible for the Ia antigenic specificities from each I 
subregion to be expressed on separate protein molecules on the cell surface (14, 
34)? Before answering this question it must be remembered that glycosyl trans- 
ferases have strict specificity requirements and thus the attachment of a sugar 
by one transferase rigorously determines the sequence of transferases which 
subsequently extend the carbohydrate chain (17, 21, 30). Thus, if it is assumed 
that the Ia-bearing protein molecule in the lymphocyte membrane is glycosyl- 
ated at  only one site  in  its  polypeptic chain,  then the first transferase that 
attaches a sugar predetermines the complete oligosaccharide sidechain which is 
constructed.  The  net  result  is  that  only  one /-subregion  oligosaccharide  is 
attached to each protein. The observation that the lymphocytes of FI mice can 
express the subregion specificities of each parent on separate molecules (14, 24) 
can also be explained in this way. 
Summary 
We have previously reported that the Ia specificities, coded for by the I region 
within the H-2 complex, appear to consist predominantly of carbohydrate. This 
conclusion was reached by examining low molecular weight Ia-bearing oligosac- 
charides isolated from mouse serum. We now report hapten-inhibition studies 
which  indicate  that  the  binding  of both  allogeneic  and  xenogeneic anti-Ia 
antibodies to the Ia glycoproteins found predominantly on B lymphocytes can be 
specifically inhibited by certain free sugars.  Both inhibition assays revealed 
that the specificity for the following Ia antigens resides predominantly in the 
following sugars:  (a) Ia. 1: N-acetyl-D-mannosamine or related sugars;  (b) Ia.3: 
a-D-galactose and related sugars;  (c) Ia.7:  L-fucose;  and  (d) Ia.15: N-acetyl-v- 
glucosamine.  It  seems  likely  that  these  sugars  are  found  at  the  terminal 
nonreducing ends of the carbohydrate portion of the Ia-bearing glycoproteins 
present in the lymphocyte membrane. In contrast, several public and private H- 
2  antigenic specificities did not appear to be sugar defined. 
These studies imply that at least some of the Ia genes from both the I-A and I- 
C subregions of the I region code for glycosyl transferases which modify oligosac- 1052  OLIGOSACCHARIDE  NATURE  OF  Ia  ANTIGENS 
charide structure and impart specificity to the Ia antigens by alteration of their 
terminal sugar residues. 
Received for publication  7 September 1976. 
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